Tianjin Medical University Cancer Institute and Hospital;
National Clinical Research Center for Cancer;
Tianjin’s Clinical Research Center for Cancer;
Tianjin 300060;
China;
Key Laboratory of Breast Cancer Prevention and Therapy;
Tianjin Medical University;
Tianjin 300060;
China;
Department of Breast Surgery;
Tianjin Medical University Cancer Institute and Hospital;
National Clinical Research Center for Cancer;
Tianjin’s Clinical Research Center for Cancer;
Tianjin 300060;
China;
Digestive Department;
Shanxi Province Tumor Hospital;
Taiyuan 030013;
Shanxi Province;
China;
Department of Hepatobiliary Surgery;
Tianjin Medical University Cancer Institute and Hospital;
Tianjin 300060;
China;
Apatinib; Hepatocellular carcinoma; Angiogenesis; Vascular endothelial growth factor receptor 2;